AMGEN INC: Ariad’s Appeal to Breach Ruling Not Yet Set for Trial
Oral argument on Ariad Pharmaceuticals Inc.’s appeal from the U.S. District Court for the District of Delaware’s patent infringement ruling in favor of Amgen Inc. remains to be scheduled.
On April…